Cargando…
SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy
Autores principales: | Gerlach, Magdalena M., Stelling-Germani, Anna, Wu, Cheuk Ting, Newrzela, Sebastian, Döring, Claudia, Vela, Visar, Müller, Anne, Hartmann, Sylvia, Tzankov, Alexandar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849564/ https://www.ncbi.nlm.nih.gov/pubmed/32299904 http://dx.doi.org/10.3324/haematol.2020.249276 |
Ejemplares similares
-
No SMAD4 hypermethylation in colorectal cancer
por: Roth, S, et al.
Publicado: (2000) -
Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other
por: Rengstl, Benjamin, et al.
Publicado: (2017) -
SMAD4 Promoter Hypermethylation in Kashmiri Colorectal Cancer Cases
por: Sameer, Aga S., et al.
Publicado: (2011) -
Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin
por: Vela, Visar, et al.
Publicado: (2021) -
SMAD3 Hypomethylation as a Biomarker for Early Prediction of Colorectal Cancer
por: Ansar, Muhamad, et al.
Publicado: (2020)